School of Medicine
Showing 241-260 of 487 Results
-
Morgan Mann
Postdoctoral Scholar, Pathology
BioMorgan W. Mann, PhD, is a postdoctoral researcher at Stanford University and clinical chemistry DABCC fellow at the University of California – San Francisco (UCSF). His personal and professional interests involve the development of novel clinical assays to streamline medical diagnostics and address emerging challenges to our healthcare systems. Prior to his joint positions at Stanford and UCSF, Morgan earned his PhD in Cellular and Molecular Pathology at the University of Wisconsin – Madison, where he applied mass spectrometry-based proteomics to study innate inflammation signaling pathways and viral protein structure in the context of airway infection. He received dual bachelor’s degrees in Biochemistry and Mathematics from the University of Oklahoma.
-
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology in solid malignancies. I currently. lead two main projects: first, using single-cell RNA Sequencing and bulk tissue genomics to discover tumor-associated macrophage (TAM) diversity and establish their prognostic and predictive markers, second: using multiplex tissue imaging (MIBI) to unravel prognostic markers of spatial heterogeneity in the colon cancer.
-
Joshua Menke
Clinical Assistant Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and cytopathology fellowship at University of California San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology and advanced single cell and cell free diagnostic techniques. As Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting as well as multiple other 12 color flow assays with the latest markers for routine phenotyping. Dr. Menke is the receipient of the Paul E. Standjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and Laurance J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboroatory. Currently, he is spearheading novel genomic and proteomic analytic techniques to study cytology samples obtained for lymphoma diagnostics, including sequencing cell-free tumor DNA from supernatant samples. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitution Collaboration (CHIC) that aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions and currently chairs that group spearheading large clinical research studies.